EU chief, Trump had 'good exchange' by phone Sunday CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S.

Hims & Hers, the high-flying online health company that rapidly grew from a buzzy startup selling Viagra to a multibillion-dollar business, had a hard month.

In an ongoing Phase 1 trial published in Nature Medicine, MB-101 was well-tolerated and 50% of patients achieved stable ...

If you're worried about not having a clean bowel movement, try chia seeds. A dietitian shares 6 ways they can relieve ...

Planned submission of IND application in 2025; Phase 1 clinical trial to follow if IND application approved No new PTSD drug ...

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, Ekterly, for a type of ...

Lexeo Therapeutics received a breakthrough therapy designation from the Food and Drug Administration for its treatment for Friedreich's ataxia. Ataxia is a rare, inherited disease that damages the ...

Costco has issued recalls on several products in 2025 due to safety concerns. Shoppers should check their purchases for ...

KalVista Pharmaceuticals shares jumped in premarket trading Monday after the company said it has received regulatory approval for its treatment of hereditary angioedema. Shares traded 20% higher ahead ...

Breakthrough Therapy designation based on interim clinical data from Phase I/II trials showing clinically meaningful ...